TeleBio
Contributes to the health and longevity of people through regenerative medicine and is committed to the creation of a prosperous society.
Corporate Philosophy
TeleBio’s vision for the future
MISSION
TeleBio aims to produce groundbreaking innovations that extend human longevity and improve QOL through R&D in the field of stem cell technology and regenerative medicine.
VISION
TeleBio will continue to pursue scientific advances and develop new biotechnology based on scientific evidence in the filed of stem cell technology and regenerative medicine.
VALUE
TeleBio aims to become a leading global company in the field of stem cell technology and regenerative medicine, and create new values for human health care.
Business overview
TeleBio conducts research and development of stem cells and secretome.
We provide the world's first human adipose stem cell secretome extract
(INCI name: Human Adipose Derived Stem Cell Conditioned Media Extract),
which is recognized as a cosmetic ingredient.
01R&D capabilities
02Brand power
03Product capabilities
04Future potential
01R&D capabilities
Research will be conducted by Mr. Kotaro Yoshimura, an eminent expert in Regenerative Medicine, Adipose-derived Stem Cells (ASC), Cosmetic Surgery and Anti-Aging.
TeleBio Inc. is the only company with which Mr. Kotaro Yoshimura is collaborating on the development of stem cell products.
02Brand power
TeleBio has assembled a team of top talents from medical societies and the industry. Our company also possesses an extensive network, in addition to our superior expertise and technical capabilities. TeleBio has been recognized by Jichi Medical University as an accredited venture of the university, while the intellectual property rights associated with the stem cell product are protected under an exclusive license.
03Product capabilities
TeleBio focuses on the commercialization of affordable, safe, and highly effective applications of human adipose stem cell secretome extract in the field of regenerative medicine, beauty, and anti-aging products. We are the only company in the world that has obtained the INCI name, Human Adipose Derived Stem Cell Conditioned Media Extract, as a cosmetic ingredient and the only company that provides it.
04Future potential
Human adipose stem cell secretome extract is expected to evolve from its current applications as a cosmetic ingredient and a research reagent into a pharmaceutical for the treatment of various aging-associated diseases and organ dysfunctions such as inflammatory diseases, motor system disorders, infertility, presbyopia, hair loss, hearing loss, etc., in the medium to term, and it is thus a product with massive market potentials.
Products
Our company offers a product lineup that harnesses cutting-edge biotechnology.
Detoxified Human Adipose Stem Cell Conditioned Medium
Joint Research
We are conducting research on the use of human adipose stem cell secretome extract with Jichi Medical University.
Research Contents and Objectives
・Establishment of methods for using human adipose stem cell secretome extract for pharmaceuticals and cosmetic materials.
・Establish methods for producing and purifying human adipose stem cell secretome extract, and investigate how to apply it to humans.
Developer
TeleBio Co., Ltd CEO
Kotaro YoshimuraProfessor and Chair at the Department of Plastic Surgery, Jichi Medical University
Prof. Yoshimura is a world-renowned expert in adipose stem cell research for the purposes of tissue regeneration and addressing aging-associated changes to the body.
He was honored by the American Society of Plastic Surgeons (ASPS) in 2016 as the Best International Researcher in recognition of his contributions over the course of his career.
CV
- [1985]
- Graduated from the School of Medicine, University of Tokyo
- [1990]
- Served as an intern at the Department of Plastic and Reconstructive Surgery, University of Tokyo Hospital
- [1994]
- PhD (University of Tokyo)
- [1994-95]
- Studied at the University of Michigan, USA
- [1998]
- Appointed as Assistant Professor at the Department of Plastic and Reconstructive Surgery, University of Tokyo
- [2015]
- Appointed as Professor and Chair at the Department of Plastic Surgery, Jichi Medical University
Company Profile
| Company Name | TeleBio Inc. |
|---|---|
| President & Representative Director | Kotaro Yoshimura (Mr) |
| Headquarter | Shimbashi Ekimae Bldg.1st #601, 2-20-15, Shimbashi, Minato-ku, Tokyo 105-0004 JAPAN |
| Research center | Open Innovation Center, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi 3290498, Japan |
| Phone | +81-3-6427-9074 |
| Scope of Business | R&D and production of stem cells, secretome, and various devices and pharmaceutical products related to tissue regeneration |